Back
Syndax Pharmaceuticals, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
SNDX
Syndax Pharmaceuticals, Inc.
Last Price:
$20.73
Seasonality Move:
13.43%
Sell
43
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.25
Seasonality Move:
0.84%
Sell
39
Syndax Pharmaceuticals, Inc. (SNDX)
is a Sell
Is Syndax Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Syndax Pharmaceuticals, Inc. [SNDX] share price is $21.07. The Score for SNDX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.25. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals, Inc.'s stock price today?
-
The Syndax Pharmaceuticals, Inc. share price today is $21.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $397.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.9 | Buy |
| Relative Strength Index (14 RSI): | 61.87 | Buy |
| Chaikin Money Flow: | -183989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.66 | Sell |
| Relative Strength Index (14 RSI): | 37.48 | Sell |
| Chaikin Money Flow: | 260878 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (393.55 - 447.35) | Sell |
| Bollinger Bands (100): | (423.62 - 470.16) | Sell |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.07 | Buy |
| 20-day SMA: | 20.43 | Buy |
| 50-day SMA: | 17.72 | Buy |
| 200-day SMA: | 13.77 | Buy |
| 8-day EMA: | 18.37 | Buy |
| 20-day EMA: | 11.65 | Buy |
| 50-day EMA: | 5.78 | Buy |
| 200-day EMA: | 1.62 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.01 | Sell |
| 20-day SMA: | 414.82 | Sell |
| 50-day SMA: | 438.02 | Sell |
| 200-day SMA: | 370.41 | Buy |
| 8-day EMA: | 400.42 | Sell |
| 20-day EMA: | 411.3 | Sell |
| 50-day EMA: | 427.39 | Sell |
| 200-day EMA: | 383.76 | Buy |
Syndax Pharmaceuticals, Inc. Earnings Growth & SNDX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $1.81 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.
Syndax Pharmaceuticals, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||